Jan 07,2021

Brighter's diabetes solutions Actiste® and Actiste® Mini have received market approval in Thailand

Brighter AB (publ) is proud to announce that the Actiste® unit and the newly developed Actiste® Mini unit have received market approval from the Thai FDA, which is a requirement to be able to start importing and marketing the products.

REGULATORY FDA

#insulin pen

View Analyst & Ambassador Comments
Go to original news
Jan 11,2021

Teladoc Health and Dexcom Bring CGM Technology and Personalized Insights to People with Type 2 Diabetes at No Cost

Teladoc Health, Inc. and DexCom, Inc. today announced that joint Livongo for Diabetes and Dexcom members will now receive CGM-powered insights, a new set of features and reports that help members more easily visualize their health information and understand how lifestyle decisions affect their blood glucose levels.

COLLABORATION PARTNERSHIP

#connected device

#cgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 11,2021

Insulet to Announce Fourth Quarter and Full Year 2020 Financial Results on February 23, 2021

Insulet Corporation today announced plans to release its financial results for the fourth quarter and full year of 2020 on February 23, 2021 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

View Analyst & Ambassador Comments
Go to original news
Jan 12,2021

BD Provides Updates To Its Fiscal 2021 Financial Outlook

Preliminary first fiscal quarter 2021 revenues of $5.3 billion grew 25.6% on a reported basis. On a currency-neutral basis, revenues increased 24.2%, driven by higher base revenues in all three segments and COVID diagnostic revenues.

View Analyst & Ambassador Comments
Go to original news
Jan 14,2021

Amalgam Rx buys clinical decision support company Avhana Health

Avhana’s platform is designed to integrate into doctor’s workflows and make suggestions about patient care, including what to add to orders. In addition to traditional orders such as additional labs, the platform can also recommend digital solutions that can be prescribed along with the treatment of care. “Why we are buying them is because we think the last mile in digital health has been making it easy for providers to know who and what to prescribe as it relates to digital, and do so in their workflow alongside the other orders that they are providing to the patient,” Chris Bergstrom, president of Amalgam Rx, told MobiHealthNews.

COLLABORATION MERGERS & ACQUISITION

#product & service

View Analyst & Ambassador Comments
Go to original news
Jan 18,2021

my mhealth appoints biotech veteran and digital therapeutics pioneer, Joel Sangerman FABC, as Chief Commercial Officer

Mr. Sangerman served as Chief Commercial Officer for Click Therapeutics, VP of Market Development for Walgreens, & Director of Reimbursement for Johnson & Johnson.

View Analyst & Ambassador Comments
Go to original news
Jan 18,2021

One Drop To Work With SCOR And Bayer On Life Insurance Products For People With Chronic Conditions

One Drop, a leader in digital solutions for people living with diabetes and other chronic conditions, today announced that global partner, Bayer, and SCOR, the fourth-largest global reinsurer, will work to bring One Drop's AI-powered digital health platform to life insurance carriers and policyholders across the United States.The partners will develop a customized life insurance solution that pairs SCOR's VELOGICA® with One Drop's evidence-based holistic health programs.

COLLABORATION PARTNERSHIP

#insurance

#coaching

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 18,2021

Insulet’s Omnipod DASH® System Now Available in Canada

The Omnipod DASH System combines a tubeless, wearable, waterproof1 Pod with an easy-to-use, touchscreen PDM.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jan 19,2021

Cecelia Health Diabetes Management Program Receives Association of Diabetes Care & Education Specialists (ADCES) Accreditation

Diabetes Education Accreditation Program (DEAP) certification underscores Cecelia Health’s commitment to providing superior care management programs to individuals living with diabetes.

View Analyst & Ambassador Comments
Go to original news
Jan 19,2021

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm to discuss its fourth quarter and full year 2020 financial and operating results.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES